EVMN · Evommune, Inc.

$12.27 +0.27 (+2.25%) At close · Sep 4

Russell 2000 member Rebalance outlook locked

Market Cap

$445.30M

36.29M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Luis Peña	Chief Executive Officer	$588,462	$740,675	—	$9,693,533	—	—	$11,022,670
Gregory S. Moss	Chief Business & Legal Officer	$515,042	$508,433	—	$3,570,591	—	$6,900	$4,600,966
Kyle Carver	Chief Financial Officer	$501,875	$496,658	—	$3,399,210	—	$6,900	$4,404,643

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Luis Peña	Chief Executive Officer	$546,083	$382,200	$565,119	$5,950,489	—	$714	$7,444,605
Gregory S. Moss	Chief Business & Legal Officer	$480,500	$269,080	$222,632	$382,548	—	$714	$1,355,474
Kyle Carver	Chief Financial Officer	$470,000	$263,200	$217,149	$286,008	—	$714	$1,237,071

Key facts CIK 2044725 CUSIP 30054Y107 13F (30d) 86 filings 86 filers Visit website Investor relations